The Union Ministry of Health and Family Welfare has removed Montu Patel from his role as President of the Pharmacy Council of India (PCI), citing that he no longer meets the membership requirements to hold office, The Times of India reported.

According to the ministry’s order, “Currently, Patel is neither a nominated member under Section 3(h) of the PCI Act, 1948, nor a member of the Gujarat State Pharmacy Council. Hence he ceases to be a member of the Central Council of PCI, thereby also ending his presidentship.”

The U.S. Food and Drug Administration (FDA) has taken a significant step forward in approving leucovorin calcium tablets for the treatment of cerebral folate deficiency (CFD) — a rare neurological condition that disrupts the transport of folate, a vitamin essential for brain development and function.

Cerebral folate deficiency has been associated with developmental delays, seizures, coordination problems, and autistic features such as challenges in social communication, sensory issues, and repetitive behaviors.